Cerevel Therapeutics Holdings
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $465,637,000.
Profit Margin
| 2012 | 5.37M | -29.41M | -547.57% |
|---|---|---|---|
| 2013 | 5.24M | -32.51M | -620.08% |
| 2014 | 2.40M | -29.32M | -1219.68% |
| 2015 | 2.72M | -28.15M | -1035.15% |
| 2018 | 0 | -463.63K | |
| 2019 | 0 | -128.38M | |
| 2020 | 0 | -152.14M | |
| 2021 | 0 | -222.44M | |
| 2022 | 0 | -351.51M | |
| 2023 | 0 | -432.84M |
CERE Income Statement (2012 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 2.72M | 2.40M | 5.24M | 5.37M |
Cost of revenue | 5.62M | 4.90M | 2.73M | 397K | 0 | 0 | 5.26M | 3.02M | 6.24M | 2.38M |
Gross profit | -5.62M | -4.90M | -2.73M | -397K | 0 | 0 | -2.54M | -617K | -1.00M | 2.98M |
Operating exp. | ||||||||||
Research and development | 334.64M | 280.25M | 161.85M | 103.30M | 50.29M | 454.65K | 9.68M | 14.15M | 16.40M | 19.15M |
Selling and marketing | -5.62M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 465.63M | 367.84M | 220.09M | 149.11M | 83.46M | 465.67K | 30.89M | 31.66M | 37.83M | 31.78M |
Operating income | -447.26M | -367.84M | -220.09M | -149.11M | -83.46M | -483.32K | -28.17M | -29.25M | -32.59M | -28.80M |
Other income (expenses), net | 14.92M | 16.49M | -5.23M | -3.05M | -44.88M | 19.68K | 22K | -63K | 80K | -605K |
Income before tax | -432.33M | -351.35M | -225.33M | -152.16M | -128.34M | -463.63K | -28.15M | -29.32M | -32.51M | -29.40M |
Income tax expense | 503K | 160K | -2.88M | -24K | 45K | 0 | -1K | -1K | -1K | 3K |
Net income | -432.84M | -351.51M | -222.44M | -152.14M | -128.38M | -463.63K | -28.15M | -29.32M | -32.51M | -29.41M |
Earnings per share | ||||||||||
Basic EPS | -2.67 | -2.32 | -1.63 | -2.07 | -1.01 | -164.94 | -1.98 | -2.06 | -2.28 | -2.06 |
Diluted EPS | -2.67 | -2.32 | -1.63 | -2.07 | -1.01 | -164.93 | -4.57 | -0.81 | -2.28 | -2.18 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |